Molecular immunology

Biomarkers for HPV-associated head and neck cancers

Epidemiology, environment, cancer risk

Auto- and anti-tumor immunity, basic immunology

Sense and response virulence mechanisms of Pseudomonas aeruginosa

Breast cancer genetics, disparities

Molecular Mechanisms in Endocrine and Neuroendocrine Tumors; Analysis of Endocrine Surgery Patient Outcomes

How specific epigenetic marks can identify patients with aggressive neuroblastoma that may benefit from alternatives to standard therapy

Computerized Analysis of Mesothelioma Tumor Volume and Response to Therapy

Health Policy and Medical Education

Intercellular communication

Colon cancer

Epigenetics, health disparities, lymphoma, and multiple myeloma

Dosimetric Impact on Toxicity and Tumor Control Following Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases in Conjunction with Immunotherapy

Clinicopathologic Features of Squamous Cell Carcinomas Involving the Parotid Gland: Primary Disease or Metastasis?

Neuroblastoma

Exploring Racial and SES Factors in Colon Cancer Screening Rates and Diagnosis

Pediatric autoimmune and neoplastic blood disease

Pharmacogenomics, chemotherapeutic response

Prostate, kidney and testicular cancer

Pediatric Ocular Findings after Stem Cell Transplantation

Breast and gynecological cancers

New uses for high-performance computing technologies

Quantitative Radiomics and Deep Learning in Medical Image Analysis for Discovery and Predictive Clinical Decision Making

Texture Analysis of Lymph Nodes in Patients with Head and Neck Cancer
Comparing Treatment Response for Necrotic Versus Solid Metastatic Lymph Nodes from Head and Neck Squamous Cell Carcinoma Based on Imaging
Radiographic Texture Analyses of Sinonasal Tumors; Quantitative Mapping of Head and Neck Tumors

Familial hematological malignancies

Molecular distinctions between estrogen, androgen, progestin, and glucocorticoid agonism and antagonism in hormone-dependent tissues and cancers and to use this information to identify, develop and characterize novel compounds that can be used as breast and prostate cancer chemopreventatives and chemotherapeutics

Dynamic and reversible RNA and DNA methylation in gene expression regulation

Osteosarcoma, bone metastasis, signaling

Role of epitranscriptomics, epigenetics, and autophagy in regulating genomic integrity and cellular homeostasis and to investigate their impact on cancer development and therapeutic resistance, with an emphasis on skin cancer including squamous cancer and melanoma

Second malignancies in childhood cancer survivors

Impact of stress of families and children whose children are critically ill

Chronic disease research and policy

Quantitative study of the protective immune function of conventional T cells, the immunosuppressive properties of regulatory T cells and the cytolytic function of natural killer cells

Breast cancer epidemiology, genetics, disparities

Understanding the biology behind polygenic risk scores

Interplay between the genetic and epigenetic alterations in carcinogenesis and disease progression, developing novel biomarkers for diagnosis and risk stratification as well as in identifying targets for therapeutic intervention

Multiple myeloma

New approaches to functional and anatomic magnetic resonance imaging, breast andprostate cancer

Metabolic Changes During Ovarian Cancer Metastasis

Neuroendocrine tumors

Underserved and minority populations, health disparities, cultural competency and cancer prevention

Tobacco cessation/High-risk behaviors, prevention, disparities

DNA damage, cell signaling, new treatments

Clostridium Difficile in Pediatric Oncologic Patients: Defining Predictive Markers for Clinical Infection

Host-Environment Interactions in Colorectal Cancer Risk and Disparities

Algorithms and algorithm-enabled imaging systems at scales from nanometers (x-ray microscopy) to meters (human computed tomography)

Ovarian, cervical and endometrial cancers

Genitourinary and gastrointestinal cancers, trials for a: phase I study of dose escalated stereotactic body RT trial for unresectable pancreatic cancer, phase II quality of life study of oral hormonal therapy with RT for prostate cancer, phase I study for oligometastatic renal cell cancer, and phase I randomized study for hepatocellular carcinoma treated with RT and immunotherapy

Nanoparticle imaging and therapeutic agents in order to overcome limitations of current diagnostic tools and therapies for cancer.

Sexuality, aging, and population health

Clinicopathologic Features of Squamous Cell Carcinomas Involving the Parotid Gland: Primary Disease or Metastasis?

Autophagy in tumor growth, metastasis

Psychosocial origins of the dramatic health disparity in cancer promoting genes between African-American women and women of Northern European ancestry.

Clinical and genomics research on blood cell development and malignancy

Adult and pediatric transplant surgery

Breast cancer treatment, disparities

Acute and chronic leukemias, chronic myeloproliferative diseases

Genitourinary malignancies and pharmacogenomics; Studying the Clinical Implementation of Pharmacogenomics, Informatics / Decision Support Tools for Clinical Application of Genomic Data

Immunotherapy and Vaccine Therapy for Cancer

Environment, genetic, and expression of asthma

Breast cancer genetics, disparities

Targeting PI3K signaling and DNA repair pathways to convert PTEN-deficient cancers from immunologically “cold” to “hot” tumors.

Machine learning, mathematical models, and artificial intelligence to predict cancer treatment outcomes from diverse types of patient information

Genetics of diabetes

Cancer risk, biomarkers, epidemiology

Tumor mechanisms

Racial and ethnic differences in colon cancer outcomes, with a focus on understanding the psychological, social and spiritual needs

Management of upper gastrointestinal cancers

Advanced solid tumors and pharmacogenetics

Cancer prevention

Role of BACH1 in Cancer Metastasis; Signaling, cell growth and metastasis

Computational analysis of complex human phenotypes

Meta-Analytic Approach in Identifying High-Risk Colon Cancer Populations

New methodologies in high- and ultra-high field MRI and MRS

Infectious disease and social network interventions

HIV/AIDS prevention, clinical trials, and health education programs for orphans and families with HIV in sub-Saharan Africa and the Americas.

How does intestinal microbes influence complications following colorectal surgery?

Hodgkin and non-Hodgkin lymphoma

Prostate, kidney, bladder, and testicular cancers

Leukemia and myelodysplastic syndromes,

Elucidating mechanisms of immunotherapy resistance in non-T cell-inflamed cancers

Prostate, bladder, kidney, and testicular cancers

Outcomes of Patients after Cytoreductive Surgery and HIPEC

Molecular Genetics of Oligometastases; Intersection of Radiotherapy and Immunotherapy; Bladder Cancer Stem Cells; Curative treatment of oligo metastasis with radiotherapy

Normal and malignant hematopoiesis

Tumor invasion and metastasis

NF-KB in Cancer and Aging